Telix QSAM, Inc. engages in the research of nuclear medicines for the treatment of cancer and related diseases and conditions. It also focuses on the development of its licensed radiopharmaceutical drug candidate, CycloSam. The company was founded on May 2, 2024 and is headquartered in Austin, TX.